Two isolates of Candida glabrata from the same stool sample from a bone marrow transplant
recipient treated with fluconazole, and designated 1084-L for large colonies on yeast extract …

A Candida (Torulopsis) glabrata strain (B57149) became resistant to fluconazole after a
patient carrying the organism was treated with the drug at 400 mg once daily for 9 days …

The emergence of antifungal resistance in Candida species has raised concern in recent
years, especially resistance toward triazole. Several newer triazole antifungal agents have …

The in vitro susceptibility of 84 isolates of Candida glabrata from patients treated at the
University Hospital of the Canary islands to eight antifungal agents (amphotericin B …

Five azole-susceptible Candida glabrata isolates obtained before 1975 became resistant to
fluconazole, itraconazole, and voriconazole within 4 days of in vitro fluconazole exposure …

Candida glabrata has emerged in recent years as a significant cause of systemic fungal
infection. We have previously reported on the first three patients receiving radiation for head …

Two isolates of Candida glabrata, one susceptible and one resistant to azole antifungals,
were previously shown to differ in quantity and activity of the cytochrome P-450 14alpha …

Since the 1990s, the substantial increase in the rate of Candida glabrata infections has
become a serious problem. As most C. glabrata infections arise from the host's endogenous …

A commercially available disk diffusion procedure was used in a large-scale study to
evaluate the susceptibility of a wide range of Candida isolates to polyenes and azoles. With …

Candida glabrata, which can become resistant to fluconazole, is a common cause of
bloodstream infection. This study was performed to determine the significance of cross …